Anthropic goes public amid market turmoil: Morningstar believes the IPO will go ahead, and that's what matters

🕒 Published on Zendoric: November 6, 2026 · 00:20
✨ AI-generated · how it's made
Barron's reports that Morningstar doesn't see this week's market slide as reason enough to halt Anthropic's IPO. More than the market noise, what matters is what it says about AI that its biggest financial deal is arriving amid so much tension.
By Barron's · November 5, 2026.
One of the biggest stock market sell-offs of the year coincides with the biggest capital markets event of the year: Anthropic's initial public offering (IPO). According to Barron's, research firm Morningstar maintains that the drop is not enough to derail the deal. The outlet notes that Anthropic is expected to go public within weeks.
The text we had access to is very brief: the rest of the article was not accessible. We therefore do not know Morningstar's specific arguments, the expected valuation or the size of the offering. It would be irresponsible to make them up, so we stick to what is documented.
Other Barron's headlines from the same days point to the source of the tension: concern over data center spending has hammered tech stocks. This is context provided by the outlet itself, not an explanation given to us by the article on Anthropic.
Our take. An IPO of this caliber is rarely canceled because of one bad week; it is delayed, repriced or resized. The fact that an analyst has to explain why they "still" believe it will go ahead shows that doubt exists in the market, and that doubt is the underlying story.
The tension is useful for understanding the moment. The market is starting to ask whether investment in AI infrastructure will be recouped through revenue. In general, that is the healthy debate every capital-intensive technology goes through before consolidating.
That is why Anthropic's prospectus is a document to watch. A listed company can no longer rely on its narrative alone; every quarter will be measured against what it stated.
Short term: volatility, contested valuations and possible corrections that could drag down the entire sector. Long term: the ability to fund increasingly powerful models with public capital is what underpins the promise of AI-accelerated medicine and research. A demanding market is not the enemy of that promise; it is the filter that forces it to prove itself.
🔗 Related on Zendoric
- Price pressure: big customers are pushing OpenAI and Anthropic toward open models · 2026-10-07
- OpenAI reportedly races to raise capital before Anthropic's IPO resets how the market values AI labs · 2026-10-20
- Anthropic prepares its market debut at $2 trillion: Amazon and Google get paid twice, as shareholders and as cloud providers · 2026-09-06


